BESPONSA Injection 1 mg Special Investigation

Clinical trial NCT05923112 · COMPLETED

Trial details

NCT number: NCT05923112
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Acute Lymphocytic Leukemia

Start date: 2018-07-02
Primary completion: 2024-09-06
Enrollment: 421

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.